Our Science
Science & Innovation
Pipeline
Company Publications
Peer Reviewed Publications
Product
Dorzagliatin
mGluR5
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Diabetes Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Company Publications
Peer Reviewed Publications
Product
Dorzagliatin
mGluR5
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Diabetes Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Announcements and Circulars
Search
Apr 08, 2021
Monthly Return
Read More
Mar 22, 2021
Grant of Share Options
Read More
Mar 19, 2021
Annual results announcement for the year ended december 31, 2020
Read More
Mar 09, 2021
Date of Board Meeting
Read More
Mar 02, 2021
Monthly Return
Read More
Feb 04, 2021
Monthly Return
Read More
Jan 08, 2021
Grant of Share Options
Read More
Jan 07, 2021
Monthly Return
Read More
Dec 18, 2020
Business Update on Completion of Dawn (Hmm0302), Dorzagliatin’S Phase III Metformin Combination Trial Announcement of Potential Inside Information
Read More
Dec 03, 2020
Monthly Return
Read More
Nov 26, 2020
Voluntary Announcement – Update Regarding Recent Business Developments Hua Medicine Announces Additional Data in Beta-Cell Function
Read More
Nov 04, 2020
Monthly Return
Read More
<<
<
1
2
3
4
5
6
7
8
9
>
>>
下一页
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Diabetes Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
Dorzagliatin
mGluR5
Subscribe Email
Focus Us
Copyright © 2020 Hua Medicine (Shanghai) Co., Ltd.
沪ICP备14036654号
沪公网安备 31011502013809号
Search